AGORA | ELEANA participates in the EU programme “PRECISESADS”
post-template-default,single,single-post,postid-11432,single-format-standard,edgt-core-1.0,ajax_fade,page_not_loaded,,hudson child-child-ver-1.0.0,hudson-ver-1.9,vertical_menu_enabled, vertical_menu_left, vertical_menu_width_290,smooth_scroll,side_menu_slide_from_right,blog_installed,wpb-js-composer js-comp-ver-5.2,vc_responsive

ELEANA participates in the EU programme “PRECISESADS”

ELEANA participated in the 3rd General Assembly of PRECISESADS from 7 to 10 March in Paris and it was represented by Ms Dora Papastavrou. PRECISESADS is a European project of clinical research on biomarkers’ development. These biomarkers could be used in developing new therapeutic approaches for people with RMD. The project is funded by EU and it is formed by 21 academics, 2 SMEs and 5 industrial partners from 12 European countries, as well as patient experts.


Share Post
No Comments

Sorry, the comment form is closed at this time.